Tag Archives: Ugur Sahin

Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according …

Berlin, Germany | Xinhua | A booster vaccination with the COVID-19 vaccine of BioNTech and Pfizer increased protection to up to 95.6 percent, the companies announced on Thursday. A randomized, controlled phase III study of more than 10,000 people aged 16 years and older found that booster vaccinations with the Comirnaty …